— Know what they know.
Not Investment Advice

IYXI OTC

Inyx, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 51 · $5234 mcap · 50M float · 0.0092% daily turnover

Cash Flow Trends

Operating Cash Flow
-$18M -98.1% ▼
Capital Expenditures
$2M -26.3% ▼
3Y CAGR: +212.8%
Free Cash Flow
-$20M -86.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$687K +249.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2002FY2003FY2004FY2005
— Operating Activities —
Net Income-$113K-$12M-$17M-$31M
Depreciation & Amort.$22K$387K$3M$7M
Stock-Based Comp.$0$0$0$0
Change in Working Capital$8K-$4M$2M-$113K
Other Non-Cash Items$41K$9M$2M$6M
Operating Cash Flow-$43K-$9M-$9M-$18M
— Investing Activities —
Capital Expenditures-$72K-$5M-$2M-$2M
Acquisitions (Net)$0$0$0-$2M
Investment Purchases$0$0$0$0
Investment Sales$0$0$0$0
Other Investing$11K$0$0$0
Investing Cash Flow-$61K-$5M-$2M-$4M
— Financing Activities —
Net Debt Issuance$0$12M$4M$22M
Stock Repurchased$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing$101K$0-$1M-$170K
Financing Cash Flow$101K$15M$11M$26M
Net Change in Cash-$3K$771K-$460K$687K
Cash End of Period$25K$796K$336K$1M
Free Cash Flow-$114K-$14M-$11M-$20M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms